Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Ferring Reflects On Fruitful 2022 As Filing Costs Hit Profits

Bagged Two FDA Approvals Just Two Weeks Apart

Mar 09 2023

• By Kevin Grogan

Ferring HQ — The Swiss group's HQ in Saint-Prex • Source: Ferring

Related Content

Finch To Wind Down, Seek Value For Pipeline Assets And IP

Jan 24 2023

Keeping Track: US FDA Oncology Approvals For Ferring’s Gene Therapy Adstiladrin And Mirati’s Targeted Therapy Krazati

Dec 18 2022

Ferring Makes Important Milestone For Microbiome With Rebyota Approval

Dec 01 2022

How The Curtain Finally Closed On Ferring/Blackstone’s Gene Therapy Venture FerGene

Oct 20 2022

Ferring’s Fecal Transplant Gets Through AdComm, Aided By Preference For Standardized Product

Sep 23 2022

Related Companies

Ferring Pharmaceuticals

Seres Therapeutics, Inc.

Finch Therapeutics Group, Inc.

FerGene

Additional Topics

Sales & Earnings Business Strategies Women's Health Commercial Approvals Gene Therapy BioPharmaceutical

More from Earnings

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window